• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

H-(Hyp)-LLPPVPLFG details
Primary information
ID antitb_1642,
Name26213786
N-Terminal modificationCallyaerins 8
C-Terminal ModificationH-(Hyp)-LLPPVPLFG
Chemical ModificationFree
Linear/CyclicAmidation
LengthHyp= Hydroxiproline, Residue 1-8 involved in cyclic bond formation
ChiralityCyclic
Nature11
SourceD
OriginCationic
SpeciesNatural
StrainDerived from Callyspongia aerizusa
Inhibition ConcentrationMycobacterium Tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis H37Rv
Cell LineIC90= 40 μg/ml
Inhibition Concentrationin vitro
Sequence2015
CytotoxicityNA
In vivo ModelNA
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1643,
Name26213786
N-Terminal modificationCallyaerins 8
C-Terminal ModificationH-(Hyp)-LLPPVPLFG
Chemical ModificationFree
Linear/CyclicAmidation
LengthHyp= Hydroxiproline, Residue 1-8 involved in cyclic bond formation
ChiralityCyclic
Nature11
SourceD
OriginCationic
SpeciesNatural
StrainDerived from Callyspongia aerizusa
Inhibition ConcentrationMycobacterium Tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis H37Rv
Cell LineMIC = 100 μg/ml
Inhibition Concentrationin vitro
Sequence2015
CytotoxicityNA
In vivo ModelNA
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1644,
Name26213786
N-Terminal modificationCallyaerins 8
C-Terminal ModificationH-(Hyp)-LLPPVPLFG
Chemical ModificationFree
Linear/CyclicAmidation
LengthHyp= Hydroxiproline, Residue 1-8 involved in cyclic bond formation
ChiralityCyclic
Nature11
SourceD
OriginCationic
SpeciesNatural
StrainDerived from Callyspongia aerizusa
Cell LineIC50= >100 μg/ml
Inhibition Concentrationin vitro
Sequence2015
CytotoxicityTHP-1 cell line
In vivo Model50% reduction in bacterial load
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1645,
Name26213786
N-Terminal modificationCallyaerins 8
C-Terminal ModificationH-(Hyp)-LLPPVPLFG
Chemical ModificationFree
Linear/CyclicAmidation
LengthHyp= Hydroxiproline, Residue 1-8 involved in cyclic bond formation
ChiralityCyclic
Nature11
SourceD
OriginCationic
SpeciesNatural
StrainDerived from Callyspongia aerizusa
Cell LineIC90 = >100 μg/ml
Inhibition Concentrationin vitro
Sequence2015
CytotoxicityTHP-1 cell line
In vivo Model90% reduction in bacterial load
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1646,
Name26213786
N-Terminal modificationCallyaerins 8
C-Terminal ModificationH-(Hyp)-LLPPVPLFG
Chemical ModificationFree
Linear/CyclicAmidation
LengthHyp= Hydroxiproline, Residue 1-8 involved in cyclic bond formation
ChiralityCyclic
Nature11
SourceD
OriginCationic
SpeciesNatural
StrainDerived from Callyspongia aerizusa
Cell LineIC50= >100 μg/ml
Inhibition Concentrationin vitro
Sequence2015
CytotoxicityMRC-5 cell lines
In vivo Model50% reduction in bacterial load
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1647,
Name26213786
N-Terminal modificationCallyaerins 8
C-Terminal ModificationH-(Hyp)-LLPPVPLFG
Chemical ModificationFree
Linear/CyclicAmidation
LengthHyp= Hydroxiproline, Residue 1-8 involved in cyclic bond formation
ChiralityCyclic
Nature11
SourceD
OriginCationic
SpeciesNatural
StrainDerived from Callyspongia aerizusa
Cell LineIC90 = 100 μg/ml
Inhibition Concentrationin vitro
Sequence2015
CytotoxicityMRC-5 cell lines
In vivo Model90% reduction in bacterial load
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),